Cervical Cancer and Genital Warts: human papillomaviruses are associated with a range of clinical manifestations including genital dysplasias, tumours and warts.

Melanoma and tumour immunotherapy: targeting the human immune system to recognise and kill cancer cells is an attractive approach to reduce tumour burden, increase quality of life, and potentially cure patients with various forms of cancer.

Hepatitis C (HCV): a major international public health problem. We are working with scientists at Chiron Corporation to develop an immunotherapeutic to treat patients with chronic HCV infection.

Liquid IVIGs: our improved products are in clinical testing.

Acute Coronary Syndromes (ACS): reconstituted high-density lipoprotein (rHDL) may be used to shrink atherosclerotic plaque in the walls of coronary arteries following heart attacks.

Topical Eye Therapy: delivery of biotech treatment for eye disease requires injection into the eye. We are working with collaborators at Flinders Medical Centre to develop topical (eye drops) delivery of biotech ophthalmic therapies.

Back | Next